BMO Launches New CDRs With Exposure to U.S. Stocks Including Apple, Intel, Mastercard, Pfizer and Visa

— BMO's CDRs trade in Canadian dollars on a Canadian exchange, giving investors exposure to international companies and greater portfolio diversification opportunities Bank of Montreal (BMO) announced five new Canadian depositary receipts (CDRs) will begin trading on the Cboe Canada exchange today. The initial offering of these new CDRs has closed. BMO's new CDRs will […]

Safe & Green Holdings Outlines New Integrated Energy Strategy Following First Year Under Olenox Leadership

Safe & Green Holdings Outlines New Integrated Energy Strategy Following First Year Under Olenox Leadership Company completes exit from modular home construction, expands into containerized energy systems, and advances vertically integrated model spanning power generation, data centers, bitcoin mining, and modular micro-refineries. GlobeNewswire November 20, 2025 The following is a letter to shareholders from the

Edible Garden Now Available at DUMBO Market and Marrazzo’s Market

Edible Garden Now Available at DUMBO Market and Marrazzo's Market GlobeNewswire November 20, 2025 Provides More Consumers in New York and New Jersey Access to the Company's Full Line of Organic Herbs and Sustainably Grown Produce Expands Edible Garden's Reach While Supporting Demand for Fresh, Clean-Label Foods BELVIDERE, NJ, Nov. 20, 2025 (GLOBE NEWSWIRE) —

Xtract One Announces Fiscal 2026 First Quarter Conference Call

Xtract One Announces Fiscal 2026 First Quarter Conference Call GlobeNewswire November 20, 2025 TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”), a leading technology-driven threat detection and security solution that prioritizes the patron access experience by leveraging AI, today announced that

Media advisory: Shriners Hospitals for Children Canada Opens Its Doors to the Public on November 29 in Honour of Its 100th Anniversary

Media advisory: Shriners Hospitals for Children Canada Opens Its Doors to the Public on November 29 in Honour of Its 100th Anniversary GlobeNewswire November 20, 2025 MONTREAL, Nov. 20, 2025 (GLOBE NEWSWIRE) — What: Families looking for an educational and fun weekend activity are invited to discover Shriners Hospitals for Children Canada during its Open

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU GlobeNewswire November 20, 2025 EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU AUSTIN, Texas, November 20, 2025 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the U.S. Food and

Nexxen Seeks Authorization for New $40 Million Ordinary Share Repurchase Program

Nexxen Seeks Authorization for New $40 Million Ordinary Share Repurchase Program GlobeNewswire November 20, 2025 NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it is seeking authorization to initiate

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates GlobeNewswire November 20, 2025 Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug's commercial potential In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY Sol-Gel signed an

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide(R) Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide(R) Cerebrospinal Fluid Assay for Metastatic CNS Cancer GlobeNewswire November 20, 2025 HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) — CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has signed a national agreement with Humana,

MicrobiotiX and West Africa Centre for Innovative Research and Care in Ghana Sign MoU to Advance Clinical Development of Bacteriophage Therapeutics and Combat AMR– MDR in Africa

MicrobiotiX and West Africa Centre for Innovative Research and Care in Ghana Sign MoU to Advance Clinical Development of Bacteriophage Therapeutics and Combat AMR– MDR in Africa GlobeNewswire November 20, 2025 SEOUL, South Korea, Nov. 20, 2025 (GLOBE NEWSWIRE) — MicrobiotiX, a company specializing in the development of novel bacteriophage therapeutics, announced on the 12th

Scroll to Top